# Evaluation of Myocardial Reperfusion After Primary PCI in Patients With High Platelet Reactivity Treated by Cangrelor or Not

> **NCT04927949** · PHASE4 · COMPLETED · sponsor: **University Hospital, Caen** · enrollment: 128 (actual)

## Conditions studied

- ST-elevation Myocardial Infarction

## Interventions

- **DRUG:** cangrelor perfusion during PCI
- **PROCEDURE:** standard PCI

## Key facts

- **NCT ID:** NCT04927949
- **Lead sponsor:** University Hospital, Caen
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-06-08
- **Primary completion:** 2023-03-31
- **Final completion:** 2023-03-31
- **Target enrollment:** 128 (ACTUAL)
- **Last updated:** 2026-04-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04927949

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04927949, "Evaluation of Myocardial Reperfusion After Primary PCI in Patients With High Platelet Reactivity Treated by Cangrelor or Not". Retrieved via AI Analytics 2026-07-18 from https://api.ai-analytics.org/clinical/NCT04927949. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*